Abstract Chikungunya virus (CHIKV), a reemerging arboviral disease of public health concern is characterized by a triad of fever, rash and arthralgia. It was responsible for a number of epidemics in Asia and Africa. The severity of the current epidemic can be judged by the fact that an estimated 1.38 million people in India and one-third of the La Reunion population (by April 2006) were affected by CHIKV. Aedes aegypti and Aedes albopictus are the major mosquitoes transmitting CHIKV in Asia. Various neurological complications and CHIKV associated deaths were encountered during the current outbreak (2005)(2006)(2007)(2008)(2009)(2010). The aggressive nature of the recent CHIKV epidemic was attributed to the mutations in the viral genome in addition to their adaptation and spread to vectors like Aedes albopictus. Proper diet, adequate rest and symptomatic treatment using non-salicylate analgesics and Non-steroidal anti inflammatory drugs (NSAIDS) helped the patients in recovering from CHIKV infections. In the absence of an effective vaccine, rapid implementation of mosquito control measures and establishment of a system for continuous surveillance of the disease seems to be the only possible solution to prevent any such outbreak in the near future.
Introduction
Chikungunya virus (CHIKV), a positive sense single stranded RNA virus belongs to the genus Alphavirus, family Togaviridae. The alphavirus genus contains 29 viruses, six of which cause human joint disorders (Chikungunya virus, O'nyong-nyong virus, Ross River virus, Barmah Forest virus, Sindbis virus, Mayaro virus) [84] . CHIKV was first reported in [1952] [1953] in Tanzania and since then has been responsible for numerous outbreaks in Africa, South East Asia and India. There has always been some linguistic confusion regarding the origin of the word Chikungunya. Some authors report it to be derived from Makonde language while some claim it to be derived from Swahili language and a recent report claimed Chikungunya to be derived from Bantu language. From the initial reports of Robinson and Lumsden and from the findings of Benjamin it is confirmed that the term Chikungunya is indeed derived from Makonde language [40] . Phylogenetic analysis based on partial E1gene sequences showed the presence of three distinct CHIKV phylogroups. The first phylogroup contained all isolates from West Africa; the second phylogroup involved all East, Central and South African strains (ECSA); and the third phylogroup contained Asian isolates. CHIKV isolates causing epidemic in 1960s and 1970s in India are of Asian genotype while the Yawat isolate (2000) and the current epidemic isolates belong to Central African genotype. CHIKV reemerged in India after a gap of 32 years and an estimated 1.38 million people were affected by the end of 2006 and which further declined to an estimated 59 thousand, 95 thousand and 68 thousand cases by the end of 2007, 2008 and 2009 , respectively [44, 45] . CHIKV has been declared as a high priority pathogen by NIH [28] . The 2006 CHIKV epidemic accounted for nearly 391 million rupees productivity loss, in India [27] . Infected viremic travelers from Kenya (2004) are held responsible for introduction of CHIKV to South Western Indian ocean islands and subsequently it spread in Asian countries [72] .
The role of Ae. albopictus in the current CHIKV outbreak was experimentally proved and established. Prominent mutation (E1A226V) in CHIKV, susceptibility to the infection among pediatric population, increasing trade and travel, successful establishment of virus into new vector species and difficulties in implementation of mosquito control measures may be some of the contributing factors in the rapid spread of CHIKV.
Origin and Geographical Distribution
CHIKV epidemic was first reported from Makonde plateau, Tanzania during 1952-1953, followed by numerous outbreaks in South Africa, Congo, Zimbabwe, Uganda, Zambia, Senegal, Nigeria, Angola [25, 54] . It was responsible for explosive epidemics in Africa, India and Southeast Asia [18, 54] . Retrospective studies suggest that the occurrence of CHIKV epidemics in 1779 were erroneously documented as dengue outbreaks [78] . The first Asian outbreak was reported from Bangkok, Thailand in 1958, followed by other Asian countries which include India, Cambodia, Vietnam, Philippines, Srilanka, Indonesia and Malaysia [25] . In India the CHIKV outbreak was first reported in 1963 in Kolkata which accounted nearly 200 deaths [78] . Existence of CHIKV antibody in human sera collected in [1954] [1955] [1956] suggested that CHIKV existed in India prior to 1963 [3, 51] . CHIKV outbreaks were recorded in Chennai, Pondicherry and Vellore in 1964; Visakhapatnam, Rajahmundry, Kakinada and Nagpur in 1965; and Barsi in 1973 [85] . CHIKV reemerged in democratic republic of Congo 
Genome Structure and Organization
Chikungunya is an enveloped virus which contains positive sense single stranded RNA as its genetic material. CHIKV particles reveal a characteristic Alphavirus morphology in green monkey kidney (Vero) cells under electron microscopy. It is about 70-100 nm in diameter by electron microscopy and atomic force microscopy [23] . The complete genome is about 11,805 nucleotides in length containing two open reading frames of about 7422 (nonstructural genes: nsP1-nsP4) and 3744(Structural genes: C, E3, E2, 6K, E1) nucleotides in length (Fig. 2) . The 5 0 end contains 7-methyl guanosine cap while the 3 0 end is polyadenylated. The genomic RNA acts as cellular messenger RNA. The nonstructural proteins are required for transcription and replication of the viral RNA and the structural proteins are involved in the replication of the virus and particularly in the interaction with the host. The junction region promotes transcription of an intracellular subgenomic 26S RNA. Antibodies directed against the E2 protein are usually virus-specific and sequence conservation in C protein and E1 glycoprotein leads to antigenic cross reactivity between alpha viruses [21] . E3 is a secreted polypeptide of unknown functions [11] . The 5 0 UTR is required for plus strand RNA synthesis [47, 76] 
and 3
0 UTR is involved in translation of viral proteins [31] . 
CHIKV Replication
The CHIKV attaches to host receptors and enters the target cell by endocytosis (Fig. 3) . After the delivery of the nucleocapsid into the cytoplasm, the CHIKV replication (Class IV) proceeds along parallel pathways. The Positive sense single stranded RNA genome (Viral genome) acts as an mRNA for the translation of the P1234 precursor and mature nonstructural proteins. RNA replication then proceeds through the synthesis of a full length minus strand RNA intermediate which is used both as a template for synthesis of genomic RNA and for the transcription of the 26S sub genomic plus strand RNA. The proteolytic processing of the P1234 nonstructural precursor regulates the transcription of positive and negative strand RNA to some extent. The cleavage product of P1234 is NSP4 which further associates with nsP123 polyprotein and with some host cellular machinery which synergistically acts as a negative strand RNA replicase. During replication when the cell concentration of nsP123 is raised sufficiently the precursor is further processed into mature proteins. The 26S sub genomic RNA serves as mRNA for the production of structural proteins. Autoproteolytic Serine Proteinase activity releases the capsid from the nascent polypeptide. The envelope polyprotein precursor is processed into pE2 and E1 which later gets associated in the Golgi complex and is exported to plasma membrane. Maturation of E1-E2 heterodimer and diffusion of mature nucleocapsids in cytoplasm occurs in parallel. The assembled virus particle consisting of an icosahedral nucleocapsid finally buds through the cell membrane and becomes an enveloped virion [11] . 
CHIKV Mouse Model Studies
CHIKV pathophysiology based on a mouse model developed by Couderc et al. [13] infers fibroblasts to be a predominant target cell. CHIKV replicates first in liver and targets muscle, joints and skin, closely resembling the cell/ tissue tropism observed in biopsy samples of CHIK infected humans. In case of severe infections CHIKV also disseminates to other tissues including the CNS, where it specifically targets the choroids plexuses and the leptomeninges. Severity of CHIKV infection depends on two host factors: age and Type-I IFN signaling. Deep joint, bone tissues, brain parenchyma, micro vascular endothelial cells, and placenta are uninfected by CHIKV [13] .
CHIKV Vectors and Virus Transmission
CHIKV Vectors and transmission cycle differs in Asia and Africa. CHIKV is maintained in a mosquito-human-mosquito cycle in Asia. Ae. aegypti is a well known vector for CHIKV transmission and the role of Ae albopictus (Asian tiger mosquito) has been experimentally proved and established during the recent outbreak [59, 64, 69, 82] . In Africa CHIKV is maintained in a sylvatic cycle involving wild primates and forest dwelling Aedes mosquitoes (Ae. africanus, Ae. furcifer, Ae. taylori, Ae. luteocephalus, Ae. neoafricanus, Ae. vittatus, Ae. fulgens, Ae. dalzieli, Ae. vigilax, Ae. camptorhynchites) [16, 37, 53] . Laboratory mice, rodents, African vervet, Asian monkeys, primates, prosimians and bats are susceptible to Chikungunya virus and develop high titre viremia [9] . The role of cattle in CHIKV transmission has also been reported [16] . Viremic human beings act as CHIKV reservoirs during the epidemics and as a precautionary measure blood donation was temporarily suspended in France to prevent transfusion transmitted CHIKV infection during the epidemic period. Ae. albopictus played a major role in CHIKV transmission in Lakshadweep [61] .
Risk Groups
In humans the virus has no age or sex specificities but it has been seen that children, elderly and immune compromised are the most severely affected. It has been reported that people living in the geographic location where the CHIKV is imported are at a major risk.
Clinical Manifestations and Complications
CHIKV infection is characterized by high fever, headache, rashes, arthralgia and myalgia. Usually the disease is self limiting and the symptoms disappear within a week. Swelling of joints, retro orbital pain, vomiting, nausea, chills are some of the other well known symptoms observed in the affected patients. Swelling of feet and rashes encountered in CHIKV infected patients from Tirupati are shown in Figs. 4 and 5. Cases with lymphodenopathy and oral ulcers were also observed [79] . The severity and presence of various symptoms varied from individual to individual. Joint involvement is usually symmetrical, polyarticular, migratory and mainly affects small joints of hand, wrist, ankle and feet [26] .Cases with hemorrhagic manifestations has also been described [43, 65, 66, 71] . Maculopapular rashes on face, trunk and limbs were observed. The severity of symptoms was more in Fig. 4 Swelling of feet, a major symptom observed in Chikungunya infected female patients during the recent CHIKV epidemic in Tirupati patients suffering from diabetes, alcoholic hepatopathy and impaired renal functions [13] . Complications with involvement of the neurological and renal system were encountered [35, 36, 74] . Mother to child transmission [60] and CHIKV associated deaths were observed [17, 36, 79] . CHIKV causes encephalopathy in neonates and incidence of vertical maternal to fetal CHIKV transmission was at the peak during intra partum period and exceptional in case of ante partum fetal contamination [12] . The joint pains lasting for as long as 3 years after the onset of disease had been reported in the past [6] . Severe thrombocytopenia and neutropenia complicated by septicemia have also been reported in a few patients. Meningo-encephalitis, meningo encephalomyeloradiculitis, myeloradiculitis, myelitis, myeloneuropathy, Guillain-Barre syndrome, external opthalmoplegia, facial palsy, sensorineural hearing loss and optic neuritis are the various neurological complications observed during the current outbreak [38] . Asymptomatic CHIKV cases were encountered in the current outbreak [40] . A study in Mayotte showed that one out of every four CHIKV affected patient was asymptomatic [73] . This shows that the estimated risk of Viremic blood donation was high during CHIKV outbreaks [8] and hence proper screening of blood during the epidemics is necessary to prevent transfusion transmitted infection. To assess the severity of various symptoms prevalent in CHIKV affected patients; a questionnaire (enquiring details regarding the prevalence and severity of various symptoms) based survey was carried out. A total of 1388 subjects from 8 different areas in Tirupati region were interviewed, data collected using the questionnaire developed and analyzed using SPSS 13.0 package. Fever, arthralgia, headache, swelling of joints and retro orbital pain were the major symptoms encountered during the present study. Our epidemiological survey suggests that irrespective of gender, CHIKV affected all age groups [39] .
Diagnosis
During the epidemic, clinical triad of fever, rashes and arthralgia is suggestive of CHIKV infection. Serum amino transferase elevation, leucopenia and anaemia are associated with the onset of CHIKV but, due to the lack in their specificity it has become necessary to rely on molecular and serological diagnostics for detection of the causative agent [25] . (Fig. 6 ) and was used for rapid screening of CHIKV suspected samples in Andhra Pradesh, India as well as Southern Thailand [41, 80] . A real time RT-PCR test has been developed for CHIKV diagnosis [19, 50, 63] . RT-LAMP assay is highly sensitive and costeffective tool, and can be used effectively during disease surveillance [48] . [24, 81] . Hemagglutination Inhibition test (HI) lacks specificity and identifies group rather than the individual virus and hence cannot be used as an accurate diagnostic test for CHIKV [29] . Indirect immunofluoroscent test (IIFT) is highly specific and sensitive tool [33] . Scientists at Singapore identified biomarkers and their association with disease severity and showed that an increase in IL-1 beta, IL-6 and a decrease in RANTES were associated with CHIKV disease severity [42] .
Differential Diagnosis and CHIKV Coinfections
Due to similarity in symptoms with other arboviral (Dengue, Sindbis, RossRiver), viral(Rubella, Parvovirus B19, alphaviruses, mumps, VZV, EBV, CMV, Measles, HTLV-1, HIV, Hepatitis), bacterial (Meningococcemia, scarlet fever, Typhoid) and parasitic diseases(Leptospirosis, malaria) differential diagnosis of CHIKV plays an important role [67] . Cases of CHIKV and dengue co infections have been reported earlier [55] . During the current outbreak CHIKV and dengue co infections were again encountered [10, 32, 68] . CHIKV co infection with amoebiasis and RSV has been observed [20, 62] .
E1:A226V Mutation and Its Importance
A single mutation in E1 gene of CHIKV was responsible for the severity of the current outbreak. Substitution of Alanine with Valine at position 226 of E1 envelope protein was observed and they speculated that this mutation reduced their cholesterol dependence to infect mosquito vectors which was later experimentally proved [69, 82] . Experiments were carried out to test the importance of A226V mutation and its role in infecting different vector species and it was observed that CHIKV isolates containing A226V mutation replicated and disseminated more efficiently in Ae. albopictus mosquitoes [83] . It was demonstrated that E1A226V mutation directly influenced vector specificity by enhancing CHIKV replication and transmission efficiency in Ae. Albopictus [82] . A226V mutation which was absent in all 2006 Indian isolates [2, 56] was found to be present in 2007 isolates from Kerala [57, 64] . Ae. albopictus vector has effectively displaced Ae. aegypti on Reunion islands and human activities such as commercial transportation of car tyres and plants further provided as a effective means for their dispersal into newer regions.
Therapeutics and Vaccines
There is no specific treatment for CHIKV infections. Adequate rest, proper diet and symptomatic treatment using non-salicylate analgesics and NSAIDS will help the patients in recovering from CHIKV infections. Paracetamol dosage of more than 3 gm/day was thought to be associated with severe liver afflictions and needs further confirmation [75] . Chloroquine is effective in treating chronic arthralgia due to its anti-inflamatory properties [5] and its use as an effective antiviral agent is under investigation. Possible use of Hydroxy chloroquine in CHIKV treatment needs further investigations in response to its extensive usage in rheumatological practices [70] . Synergistic efficacy was reported between interferon-a and ribavirin on CHIKV replication in invitro conditions [7] . Human polyvalent immunoglobulins, obtained from CHIKV infection convalescent donors (CHIKVIg) protected the experimental animals against CHIKV severity. Such a mode of treatment would be preferred for treating neonates born to viremic mothers as well as immuno compromised patients [14] . Inspite of the promising results shown during the phase II trials, the CHIKV vaccine (TSI-GSD-218) project had to be interrupted to focus on other infectious agents posing bioterrorism threat. Currently the phase III trials of the US army candidate vaccine is under progress [53] . RNA interference mediated inhibition of viral replication has emerged as a promising antiviral strategy and has been shown to inhibit partial to complete viral replication of several human and animal viruses like Polio virus, CMV, EBV, RSV, Influeza virus, FMDV, West Nile virus, HIV [58] . The effectiveness of siRNA mediated invitro replication of CHIKV was also demonstrated and it offered a potential new therapeutic approach [15] . Virus like particle (VLP) vaccine for viruses such as Hepatitis B and human Papillomavirus has already been approved by the Food and Drug Administration. An experimental vaccine developed using non-infectious VLP has shown promising results on macaques and mice against Chikungunya virus and its further evaluation on humans will be done in the near future [1] .
Prevention and Control

Protective Measures Against Mosquito Bites
Ae. aegypti lives in close association with humans and A. albopictus prefers both domestic and peri domestic areas for breeding [46] . Ae Aegypti is active during early morning and the last 3-4 h of day light. Hence protective measures against mosquito bites such as usage of Mosquito nets (indoor protection); wearing full sleeve clothes (Outdoor protection) and usage of repellant containing 30-50% DEET as recommended by CDC are the important protection measures against mosquito bites. Gambusia and guppy or local species of cyclopoid copepods can be introduced to water tanks and cisterns as a control measure. Bacillus thuringiensis israelensis, is also used as a biological larvicide.
Surveillance
Epidemiological and entomological surveillance needs to be intensified. Reporting of fever cases should be monitored closely. This will help in identifying area for initiating control measure. Medical and Health Institution, professional association, private practitioners, NGOs should be involved for fever reporting and proper case management.
IEC Activities
IEC activities are crucial for community sensitization and participation. People need to be educated about the disease, mode of transmission, availability of treatment and adoption of control measures. The activities have to be intensified particularly to effect changes in practice of storage of water and personal protection. Special campaigns may be carried out with the involvement of mass media including local vernacular newspaper/magazines, radio and TV as well outdoor publicity like hoardings, miking, drum beating, rallies, etc. Health education materials should be developed and widely disseminated in the form of posters, pamphlets, handbills, hoardings, inter-personal communication through group meetings; traditional/folk media particularly must be optimally utilized.
Concluding Remarks and Challenges Ahead
• To understand the survival nature of CHIKV during inter epidemic periods • To study the possible role of seasonal migratory birds and vertebrate reservoir hosts such as rodents in the maintenance of CHIKV.
• To study the differential role of different species of mosquitoes in CHIKV maintenance and transmission.
• Proper arrangement for supply of diagnostic kits during the epidemics.
• To carry out epidemiological studies and proper implementation of mosquito control measures during the epidemics.
